Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients

Nigel Mackman; Henri M. H. Spronk; George A. Stouffer; Hugo ten Cate

doi:10.1161/ATVBAHA.117.310048

Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients

Nigel Mackman^*, Henri M. H. Spronk, George A. Stouffer, Hugo ten Cate

^*Corresponding author for this work

Research output: Contribution to journal › (Systematic) Review article › peer-review

Original language	English
Pages (from-to)	726-732
Number of pages	7
Journal	Arteriosclerosis Thrombosis and Vascular Biology
Volume	38
Issue number	4
DOIs	https://doi.org/10.1161/ATVBAHA.117.310048
Publication status	Published - 1 Apr 2018

Keywords

anticoagulants
apolipoprotein
coronary artery disease
myocardial infarction
patients
E-DEFICIENT MICE
ATHEROSCLEROTIC LESION DEVELOPMENT
PRIOR MYOCARDIAL-INFARCTION
PROTEIN-C ANTICOAGULANT
ATHEROTHROMBOTIC EVENTS
PROTHROMBIN DEFICIENCY
CARDIOVASCULAR-DISEASE
SECONDARY PREVENTION
EMBRYONIC LETHALITY
THROMBIN INHIBITION

Access to Document

10.1161/ATVBAHA.117.310048

https://europepmc.org/articles/pmc5978740?pdf=renderLicence: Other

Cite this

@article{63568c6ffc77490c9cf9ae2dc0d48ead,

title = "Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients",

keywords = "anticoagulants, apolipoprotein, coronary artery disease, myocardial infarction, patients, E-DEFICIENT MICE, ATHEROSCLEROTIC LESION DEVELOPMENT, PRIOR MYOCARDIAL-INFARCTION, PROTEIN-C ANTICOAGULANT, ATHEROTHROMBOTIC EVENTS, PROTHROMBIN DEFICIENCY, CARDIOVASCULAR-DISEASE, SECONDARY PREVENTION, EMBRYONIC LETHALITY, THROMBIN INHIBITION",

author = "Nigel Mackman and Spronk, {Henri M. H.} and Stouffer, {George A.} and {ten Cate}, Hugo",

year = "2018",

month = apr,

day = "1",

doi = "10.1161/ATVBAHA.117.310048",

language = "English",

volume = "38",

pages = "726--732",

journal = "Arteriosclerosis Thrombosis and Vascular Biology",

issn = "1079-5642",

publisher = "Lippincott Williams & Wilkins",

number = "4",

}

TY - JOUR

T1 - Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients

AU - Mackman, Nigel

AU - Spronk, Henri M. H.

AU - Stouffer, George A.

AU - ten Cate, Hugo

PY - 2018/4/1

Y1 - 2018/4/1

KW - anticoagulants

KW - apolipoprotein

KW - coronary artery disease

KW - myocardial infarction

KW - patients

KW - E-DEFICIENT MICE

KW - ATHEROSCLEROTIC LESION DEVELOPMENT

KW - PRIOR MYOCARDIAL-INFARCTION

KW - PROTEIN-C ANTICOAGULANT

KW - ATHEROTHROMBOTIC EVENTS

KW - PROTHROMBIN DEFICIENCY

KW - CARDIOVASCULAR-DISEASE

KW - SECONDARY PREVENTION

KW - EMBRYONIC LETHALITY

KW - THROMBIN INHIBITION

U2 - 10.1161/ATVBAHA.117.310048

DO - 10.1161/ATVBAHA.117.310048

M3 - (Systematic) Review article

C2 - 29449336

SN - 1079-5642

VL - 38

SP - 726

EP - 732

JO - Arteriosclerosis Thrombosis and Vascular Biology

JF - Arteriosclerosis Thrombosis and Vascular Biology

IS - 4

ER -